What Does Ekso Bionics Holdings (EKSO) Do? — Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters at a Glance
A US medical robotics company that develops and sells wearable robotic exoskeletons, including EksoNR for the rehabilitation of stroke and spinal cord injury patients.
Subscribe🏢 What kind of company is Ekso Bionics?
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) is a US-based medical robotics company headquartered in Northern California that develops and sells wearable robotic exoskeletons. Its product lineup includes EksoNR, which aids rehabilitation for stroke and spinal cord injury patients, as well as the lower-limb assistive device Ekso Indego and the upper-body work-assist Ekso EVO, which it supplies to hospitals and rehabilitation centers. More recently, the company has unveiled an AI voice-control feature powered by NVIDIA Jetson, evolving into a smart rehabilitation robot.
💰 How does it make money?
Revenue is generated through two segments: Enterprise Health (hospitals and rehabilitation facilities) and Personal Health (individual users). The main sources of income are device sales and lease fees, along with maintenance services. Q3 2025 revenue came in at $4.2 million (+2% year-over-year), and in December 2025 the company secured the exclusive US distribution rights for the MediTouch BalanceTutor rehabilitation system, broadening its product lineup.
| Business Segment | Main Products | Customers |
|---|---|---|
| Enterprise Health | EksoNR (lower-limb rehabilitation), MediTouch BalanceTutor | Hospitals, rehabilitation centers |
| Personal Health | Ekso Indego Personal (personal lower-limb assistive device) | Individual patients with spinal cord injuries |
| Industrial / Other | Ekso EVO (upper-body assist exoskeleton) | Manufacturing workers |
📐 Market Cap and Company Scale
The market cap stands at $42.0M, roughly About 0% of Samsung Electronics' market cap. The company has 55 people employees and is headquartered in North Richmond, California. Although a pioneer in the medical exoskeleton robot field, it is a small medical device company with a market cap of about $38 million.
📈 Ekso Bionics Outlook and Stock Price Trends
1-Year Price Performance
Analyst Consensus
52-Week Price RangeAging societies and growing demand for rehabilitation medicine create favorable long-term conditions for Ekso Bionics. The integration of AI voice control (powered by NVIDIA Jetson) and the acquisition of MediTouch exclusive distribution rights are positive signals for product competitiveness. However, quarterly revenue volatility is significant (Q2 2025 was -58% year-over-year), and persistent net losses remain a burden. Additional uncertainty stems from the fact that the company is currently conducting a major review of its business strategy, including the potential sale of the business or a pivot to a different industry.
⚔️ Key Competitive Strengths and Risks
The company holds a leading position in the medical exoskeleton field, but irregular earnings and strategic uncertainty are weighing on investor sentiment.
💪 Key Competitive Strengths
⚠️ Key Risks
Below are the firms that compete with Ekso Bionics in the medical robotics and rehabilitation device space, as well as related stocks.
- ReWalk Robotics (RWLK): An Israel-based medical exoskeleton specialist. A direct competitor developing lower-limb rehabilitation exoskeletons that compete with EksoNR.
- Intuitive Surgical (ISRG): The global leader in da Vinci surgical robots. As a major player in the medical robotics field, it has the potential to enter the rehabilitation robot market.
- Stryker (SYK): A global giant in orthopedic and rehabilitation medical devices. An indirect competitor in the rehabilitation solutions business.
Related stocks (beneficiaries): NVIDIA's (NVDA) Jetson edge AI platform serves as a core component in Ekso's AI exoskeleton development. Stocks tied to demand for rehabilitation and orthopedic devices — such as Zimmer Biomet (ZBH) and Parker Hannifin (PH) (a partner in the industrial exoskeleton space) — are also related names.
Compare real-time quotes and financial metrics for each stock in the table below.
Competitors| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | $369.68 | +2.6% | $130.6B | 42.4 | 7.2 | 17.43% | - |
| SYK | Stryker Corp | $275.56 | +2.1% | $105.7B | 28.6 | 4.4 | 16.51% | 1.28% |
Related stocks (beneficiaries)| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| NVDA | NVIDIA Corp | $218.22 | -0.1% | $5.26T | 27.6 | 23.0 | 117.21% | 0.34% |
 ZBH | Zimmer Biomet Holdings Inc | $93.49 | +1.1% | $17.8B | 22.8 | 1.4 | 6.42% | 1.11% |
| PH | Parker-Hannifin Corp | $950.23 | +1.7% | $119.8B | 33.4 | 7.8 | 25.08% | 0.84% |
✅ Investor Checkpoints
Ekso Bionics is a leader in the future-growth field of medical rehabilitation robots, but at the current stage, business strategy uncertainty and persistent losses are major obstacles. It remains to be seen whether AI integration and distribution network expansion will translate into improved earnings.
| Checkpoint | What to Confirm | Current Status |
|---|---|---|
| 🔍 Strategic Direction | Will the review of a potential sale or business pivot conclude favorably for shareholders? | ⚠️ Under review |
| Revenue Stabilization | Is quarterly revenue volatility easing and a growth trend becoming visible? | High volatility |
The rehabilitation robot market is a long-term growth sector, but in the short term, the strategic review and earnings volatility are adding considerable uncertainty to the stock. Maintaining a small position of interest and waiting to enter after the strategic direction is confirmed is a way to reduce risk.
In summary, Ekso Bionics is a small medical device company with a leading brand in the medical exoskeleton robot space, where AI integration and distribution expansion serve as growth catalysts. Patience is required as investors wait for strategic uncertainty to be resolved and earnings to stabilize.
Check Ekso Bionics' real-time quotes, technical indicators, and peer comparisons at a glance on US Stock Today's real-time dashboard.
Subscribe Today's 5 AI picks, all free